Concepedia

Publication | Open Access

Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers

301

Citations

33

References

2011

Year

Abstract

Selumetinib displays interesting activity and acceptable tolerability in patients with metastatic BC. Our results warrant further evaluation of selumetinib in patients with metastatic BC.

References

YearCitations

Page 1